Key result
Transaortic thromboembolectomy successfully clears large LV thrombus in COVID-19 NSTEMI, improving neurological recovery.
Why the study?
Left ventricular thrombosis is a known complication of myocardial infarction, and COVID-19 produces a procoagulant state causing venous and arterial thrombosis.
Case Report (n=1)
No
Surgical transaortic thromboembolectomy is a viable option for removing a left ventricular thrombus in patients with COVID-19 and NSTEMI who fail or have contraindications to medical management.
May offer an alternative for refractory LV thrombus in COVID-19 NSTEMI; leaves open the need for prospective validation.
Left ventricular thrombosis is a known complication of myocardial infarction. COVID 19 has been shown to produce a procoagulant state resulting in venous and less commonly arterial thrombosis. Here, we describe a patient who presented with a non-ST elevation myocardial infarction (NSTEMI), in the context of a COVID 19 infection. This NSTEMI resulted in the formation of a large pedunculated apical thrombus, which was initially managed conservatively, however ultimately required surgical thromboembolectomy. Access to the left ventricle was gained via the transaortic route in order to avoid ventriculotomy in a patient with a reduced LV systolic function. Post-operative imaging confirmed complete resection of thrombus.
No takes yet. Share an insight, caveat, or question.
Janula et al. (2021) conducted a case report in Left ventricular thrombus following NSTEMI and COVID-19 (n=1). Surgical transaortic thromboembolectomy was evaluated on Complete resection of thrombus. Surgical transaortic thromboembolectomy successfully removed a large left ventricular thrombus in a patient with COVID-19 and NSTEMI, leading to clinical and neurological improvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: